Dr Ndinda Kusu is the Country Project Director with the USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program and the team lead for Management Sciences for Health in Kenya. She is a clinical pharmacist and an experienced public health, program management and health system strengthening specialist with over 25 years of experience working with public, private, and faith-based health sectors strengthening health and pharmaceutical systems to increase access to and use of medicines and health technologies.


She has done immense work in governance, human and institutional capacity development; development and implementation of policies, guidelines, curricula, and tools; implementing continuous professional development; supporting continuous quality improvement, promoting rational use; curbing antimicrobial resistance and strengthening regulatory systems.


She has a passion for promoting patient safety through pharmaceutical care, infection prevention control (IPC) and pharmacovigilance systems strengthening. Ndinda has spearheaded premier initiatives such as the introduction of the Kenya Pharmacovigilance Electronic Reporting System, curricula reform, and introduction of a postgraduate Masters’ course on Pharmacoepidemiology and Pharmacovigilance at the University of Nairobi.


In support of African Medicines Regulatory Harmonization (AMRH) agenda, Ndinda worked with the East African Community (EAC) Secretariat, Intergovernmental Authority on Development (IGAD) and other AMRH partners to support the EAC and IGAD Medicines Regulatory Harmonization Initiative through the development and implementation of harmonized regional guidelines, tools and approaches. She is a member of several health professional associations and committees.

Ndinda holds a Bachelor’s degree in Pharmacy and Masters’ degrees in Clinical Pharmacy and Public Health


WHO consultant, Scientific board member at the International Society of Pharmacovigilance (ISoP), President of ISoP Egypt Chapter. Co-founder and former head of the Egyptian Pharmacovigilance Center, Pharmacovigilance Lecturer at MSA University. She was a principal contributor in issuing the “Good Pharmacovigilance Practice guidelines in Arab Countries” (GVP-Arab). At that time, she introduced new regulatory concepts to boost the PV practice at affiliate level for international pharmaceutical companies (e.g. Pharmacovigilance sub-system file “PSSF” & national display of a RMP). And established the national Pharmacovigilance Inspection program. She played an important role in strengthening Pharmacovigilance practice in Egypt and integrating pharmacovigilance teaching in Academia. She participates in numerous pharmacovigilance & medication safety training at the national and international levels. She supervised several pharmacovigilance research projects and had a list of publications in medication safety.


Libert Chirinda is a Chief Regulatory Officer in the Pharmacovigilance and Clinical Trials (PVCT) Division at the Medicines Control Authority of Zimbabwe (MCAZ), where he is involved in managing vigilance activities as well as clinical trials oversight activities.

He has more than eight years’ experience in pharmacovigilance activities and regulatory affairs, and has been part of the PVCT Division, which is also the National Pharmacovigilance Centre for Zimbabwe, since 2013. He has been involved in several pharmacovigilance initiatives locally, regionally, and internationally, and seeks to improve pharmacovigilance systems in Zimbabwe and beyond.

He holds a Bachelor of Pharmacy Degree from the University of Zimbabwe (UZ), as well as a Master of Health Sciences Degree in Pharmacovigilance from the University of KwaZulu-Natal (UKZN).

Outside the work environment, Libert can usually be found playing chess or reading. Libert has been an avid reader for as long as he can remember, and his choice of literature spans across genres.


Zakaria holds a Doctoral degree in pharmacy from Algeria and a Pharmacovigilance certificate from France,


He started his career in Pharmacovigilance at Roche Pharmaceutical, where he has also served in different roles in Medical Affairs and Products quality.


Zakaria joined Boehringer Ingelheim in February 2019 as Local Pharmacovigilance Manager for North-West Africa Region and is currently, Regional Pharmacovigilance Lead for IMETA region (India, Middle East, Turkey and Africa) based in Dubai-UAE.


Anna is medicines information and safety pharmacist with a Master’s of Science in Clinical Pharmacology. She has been heading the national pharmacovigilance centre for over 6 years. Prior to joining the regulatory authority in 2015, she worked in hospital pharmacy where she was also the focal person for pharmacovigilance.

She is the national focal person in the ongoing EDCTP funded project (April 2020 – March 2023) aimed at Strengthening Pharmacovigilance and Regulatory Capacities in four Southern African countries (SPaRCS).

Anna serves as a member of the Namibia Essential Medicine List committee as well as the Education Committee of the Pharmacy Council of Namibia.


Lebogang has over 12 years of working experience in the Pharmaceutical Industry, a fully registered Pharmacist with the Botswana Health Professions Council graduated with a Bachelor of Pharmacy from the Latrobe University, Bendigo Australia.

A Pharmacovigilance Manager with the Botswana Medicines Regulatory Authority (BoMRA), Lebogang has a firm grip in the Drug Regulatory systems, Market dynamics and pharmaceutical industry, currently responsible for core PV operational functions including Case Management, and Quality and Document Management, managing the operation infrastructure required to oversee all aspects of adverse event collection, processing, and reporting from clinical trials.

As the Immediate Past President of The Pharmaceutical Society of Botswana, Lebogang is involved in the development of Campaigns that promote health care industry and has gone to develop strategic relations and collaborations with stakeholders within the health industry in Botswana and the SADC region. A member of the Commonwealth Pharmacist Association Council, his role includes but not limited to advocating for collaboration and partnership amongst the Commonwealth Pharmacy Associations. A member of the joint taskforce for the Ministry of Health & Wellness and Business Botswana mandated with developing strategic projects that will see private sector collaboration in public healthcare delivery. Also, member of International Society of Pharmacovigilance

LK as he is affectionally known prides himself with the development of safety exchange agreements with license partners and distributors in support of PV collaborations, a firm believer that accomplishments validate facts you already know while setbacks teach the hard lessons.


MRS HOUDA SEFIANI is medical doctor, graduated from Rabat University School of medicine, Morocco. Specialized in pharmaco-toxicology. She has a PHD in Health Vigilances field.


She began her career as practitioner during 4 years before integrating the WHO Collaborating Centre: Moroccan Poison Control Centre and Pharmacovigilance Centre, in 2007.


Since 2007: working in pharmacovigilance activities, focusing on cases analysis, causality assessment, signal detection and risk minimization actions.

Since 2008: Involved in different training and pharmacovigilance development projects in collaboration with the World Health Organization, Monitoring Medicines Project, Uppsala Monitoring Centre and the Moroccan Pharmacovigilance Centre, to promote Pv in Africa and MENA region and to develop new tools to manage ADRs.


Since 2014, She is member of ATC-DDD WHO Working group.


is a Pharmacovigilance (PAVIA) coordinator in Eswatini. Alemayehu is a pharmacy professional with advanced skills around pharmaceutical services and pharmacovigilance (Patient safety). He has over ten years of proven experience in pharmaceutical services, academia and pharmacovigilance at national, regional and facility levels.

In his current role as a Pharmacovigilance Africa (PAVIA) coordinator with Eswatini National Pharmacovigilance center, he coordinates pharmacovigilance activities and provide technical assistance to the National pharmacovigilance center in the Government of the Kingdom of Eswatini to strengthen the pharmacovigilance system.

He previously worked with various USAID-funded projects including Management Science for Health (MSH)/SIAPS project as a Technical Advisor-patient safety as well as in Universities in Eswatini as a Lecturer.

Alemayehu holds a bachelor’s degree in Pharmacy, a master’s degree in clinical research and currently pursuing his Ph.D. in pharmacovigilance and pharmacoepidemiology at the University of Bordeaux, France through EU2P program. He has also done various PV training with different institutions.


Florah is a pharmacist by profession currently heading the pharmacovigilance unit of South African Health Products Regulatory Authority (SAHPRA). She holds BPharm and master’s in pharmacy with specialisation in Pharmacovigilance & Pharmacoepidemiology. She joined SAHPRA in 2011 as Medicine Registration Officer in the Pharmaceutical & Analytical Directorate and later Head the Vigilance unit since October 2015 to date. She has experience in different pharmacy sectors, including medicines regulation, retail and hospital pharmacy. She has attended different pharmacovigilance courses offered internationally including training by Uppsala Monitoring Centre.


She supports the National Immunisation Safety Expert Committee and member of African Union Smart Safety Surveillance (AU-3S) Joint Signal Management Group, aimed at facilitating cross-country signal management for COVID-19 vaccines in Africa, to support action in the interest of public health and safety.


Professor Riadh DAGHFOUS is a Doctor of Medicine MD. He received the title of Physician Resident for Hospitals of Paris in 1990 and obtained his specialty in Pharmacology at the University of Tunis during the same year. He became an Assistant lecturer in Pharmacology at the Faculty of Medicine of Tunis in November 1991 and Associate Lecturer in December 1996 and now he is a professor of pharmacology since December 2004.

He has held several teaching positions including the position of coordinator of Pharmacology teaching (from 2002 to 2008) in the Faculty of Medicine of Tunis.

At the national level, he is now the Head (General Director) of the Tunisian National Center of Pharmacovigilance since January 2017and, the head of Covid-19 scientific vaccination committee and member of the Tunisian Health Ministry COVID-19 scientific committee, since 2021.

Professor Riadh DAGHFOUS is a member of the Clinical Pharmacology Research Laboratory of the National Center for Pharmacovigilance and of the Pharmacology Research Unit at the Faculty of Medicine of Tunis and is also a national expert in clinical trials since 1999. He’s an author of numerous national and international publications.

At the international level, he occupies the position of Tunisia representing in the WHO for the international network for the surveillance of pre-qualified vaccines.

He has been a founding member of the African society of pharmacovigilance since 2012 and a member of the International Society of Pharmacovigilance since 2001.